Alkem Laboratories Ltd share price logo

Alkem Laboratories Ltd

NSE: ALKEM

BSE: 539523

Mid Cap

Pharma Sector

₹5498.00

+46.50

(+0.85%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Earnings & Guidance Alert

Alkem Laboratories reported Q4 profit decline, recommended ₹10 dividend, and guided for strong FY27 growth with new product launches and positive brokerage ratings.

Alkem Labs Stock Performance

as on May 29, 2026 at 9:32 pm IST

  • Day's Low

    Day's High

    ₹5,472.00
    ₹5,789.00
    downward going graph

    0.47%

    Downside

    5.29%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹4,716.20
    ₹5,933.50
    downward going graph

    14.22%

    Downside

    7.92%

    Upside

    downward going graph

Alkem Labs share price movements today

Previous Close
₹5,451.50
Open
₹5,578.00
Volume
14.05L
Upper Circuit
₹5,996.50
Lower Circuit
₹4,906.50
Day's Low - High
₹5,472.00 - ₹5,789.00
52 Week Low - High
₹4,716.20 - ₹5,933.50

Alkem Labs Historical Returns

1 Month Return
+ 2.01 %
3 Month Return
-2.06 %
1 Year Return
+ 2.97 %
3 Year Return
+ 62.81 %
5 Year Return
+ 82.37 %

Alkem Labs Fundamentals

as on May 29, 2026 at 4:02 pm IST

Market Cap

₹65,180.86 Cr

Return on Equity (ROE)

19.94

PE Ratio (TTM)

28.32

Return on capital employed (ROCE)

20.29

Industry PE ratio

46.01

Beta (LTM)

0.78

P/B Ratio

4.73

Dividend Yield

0.92

PEG Ratio

2.48

Quarterly Earnings Growth YOY

-22.08

EPS (TTM)

185.36

Book Value

1002.5

Alkem Labs Stock Valuation

as on May 29, 2026 at 4:02 pm IST

Alkem Labs in the last 5 years

  • Overview

  • Trends

Lowest (20.07x)

March 24, 2021

Today (28.32x)

May 27, 2026

Industry (46.01x)

May 27, 2026

Highest (44.21x)

August 9, 2023

LowHigh

Today’s Price to Earnings Ratio: 28.32x

Alkem Labs Technical Analysis

Track how Alkem Labs technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish8
Bullish6
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
-7.95
Bullish
CCI (20)
607.17
Bearish
RSI (14)
50.68
Neutral
Momentum (10)
-1
Bearish
ADI (14)
50.37
Bullish
Ultimate Oscillator (7,14,28)
19.19
Bearish

Moving Averages

Name

Value

Action

SMA (20)
5486.9
Bullish
EMA (20)
5493.46
Bullish
VWMA (20)
5487.98
Bullish
SMA (50)
5521.64
Bearish
EMA (50)
5514.76
Bearish
SMA (200)
5555.42
Bearish
EMA (200)
5547.63
Bearish
KAMA (200)
5498.25
Bullish
DEMA (200)
5538.96
Bearish

Alkem Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alkem Labs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Alkem Laboratories Ltd image
Alkem Laboratories Ltd
BUY65,180.8616.47%0.592,21612,964
Dr Lal Pathlabs Ltd image
Dr Lal Pathlabs Ltd
BUY27,110.381.88%0.544922,461
Laurus Labs Ltd image
Laurus Labs Ltd
HOLD74,591.9832.76%0.713545,553
Vijaya Diagnostic Centre Ltd image
Vijaya Diagnostic Centre Ltd
BUY12,979.3920.68%0.65143704
Thyrocare Technologies Ltd image
Thyrocare Technologies Ltd
BUY8,151.658.88%0.5390687
See all

Market expectation of Alkem Labs Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

50.00%

Buy

33.33%

Hold

16.67%

Sell

Alkem Labs Stock’s Investor Sentiment and Interest

Search interest for Alkem Laboratories Ltd Stock has increased by 49% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:49% versus previous 30 day period

Alkem Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
2,967.72
3,440.17
3,323.87
2,935.82
3,031.82
3,414.67
3,374.28
3,143.75
3,371.14
4,000.99
3,736.82
3,603.32
Other Income
65.84
63.19
93.64
88.17
120.31
134.48
92.99
145.96
149.42
103.69
143.1
200.07
Total Income
3,033.56
3,503.36
3,417.51
3,023.99
3,152.13
3,549.15
3,467.27
3,289.71
3,520.56
4,104.68
3,879.92
3,803.39
Expenses
2,578.53
2,751.1
2,667.59
2,546.36
2,423.18
2,661.84
2,614.89
2,752.46
2,632.09
3,080.22
2,961.61
3,220.9
Operating Profit
389.19
689.07
656.28
389.46
608.64
752.83
759.39
391.29
739.05
920.77
775.21
382.42
Operating Profit Margin %
13.11%
20.03%
19.74%
13.27%
20.08%
22.05%
22.51%
12.45%
21.92%
23.01%
20.75%
10.61%
Profit Before Interest, Tax and Depreciation
455.03
752.26
749.92
477.63
728.95
887.31
852.38
537.25
888.47
1,024.46
918.31
582.49
Interest
29.77
30.32
25.46
26.86
29.11
28.14
36.03
28.42
29.78
35.02
42.1
53.88
Depreciation
72.41
73.9
69.56
83.43
80.48
78.91
85.28
112.49
87.68
93.61
95.01
105.76
Profit Before Tax
352.85
648.04
654.9
367.34
619.36
780.26
731.07
396.34
771.01
895.83
781.2
422.85
Tax Paid
65.04
33.15
50.62
62.86
69.12
78.3
90.28
73.33
102.69
116.23
127.67
171.17
Profit After Tax
287.81
614.89
604.28
304.48
550.24
701.96
640.79
323.01
668.32
779.6
653.53
251.68
Total Net profit including share of profit / Loss from associate company
287.81
614.89
604.28
304.48
550.24
701.96
640.79
322.39
667.91
779.11
653.03
251.11
EPS
23.98
51.9
49.76
24.55
45.6
57.6
52.34
25.57
55.56
63.99
53.19
19.77
Actual EPS
23.98
51.9
49.76
24.55
45.6
57.6
52.34
25.57
55.56
63.99
53.19
19.77
Adjusted EPS
23.98
51.9
49.76
24.55
45.6
57.6
52.34
25.57
55.56
63.99
53.19
19.77
Diluted EPS
23.98
51.9
49.76
24.55
45.6
57.6
52.34
25.57
55.56
63.99
53.19
19.77

Alkem Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
6,401.17
7,357.19
8,344.36
8,865.01
10,634.19
11,599.26
12,667.58
12,964.52
14,712.27
Other Income
115.42
87.7
104.22
233.21
162.65
216.08
310.84
493.74
583.35
Total Income
6,516.59
7,444.89
8,448.58
9,098.22
10,796.84
11,815.34
12,978.42
13,458.26
15,295.62
Expenses
5,392.25
6,242.42
6,870.97
6,922.62
8,596.23
10,092.79
10,543.58
10,452.37
11,881.89
Operating Profit
1,008.92
1,114.77
1,473.39
1,942.39
2,037.96
1,506.47
2,124
2,512.15
2,830.38
Operating Profit Margin %
15.76%
15.15%
17.66%
21.91%
19.16%
12.99%
16.77%
19.38%
19.24%
Profit Before Interest, Tax and Depreciation
1,124.34
1,202.47
1,577.61
2,175.6
2,200.61
1,722.55
2,434.84
3,005.89
3,413.73
Interest
55.33
54.63
65.06
58.92
52.37
107.36
112.41
121.7
160.78
Depreciation
143.03
193.18
252.76
274.58
303.96
310.42
299.3
357.16
382.06
Profit Before Tax
925.98
954.66
1,259.79
1,842.1
1,844.28
1,304.77
2,023.13
2,527.03
2,870.89
Tax Paid
287.56
181.02
110.48
224.33
163.96
297.96
211.67
311.03
517.76
Profit After Tax
638.42
773.64
1,149.31
1,617.77
1,680.32
1,006.81
1,811.46
2,216
2,353.13
Total Net profit including share of profit / Loss from associate company
638.42
773.64
1,149.31
1,617.77
1,680.32
1,006.81
1,811.46
2,215.38
2,351.16
EPS
52.77
63.61
94.26
132.57
137.63
82.31
150.19
181.11
192.51
Actual EPS
52.77
63.61
94.26
132.57
137.63
82.31
150.19
181.11
192.51
Adjusted EPS
52.77
63.61
94.26
132.57
137.63
82.31
150.19
181.11
192.51
Diluted EPS
52.77
63.61
94.26
132.57
137.63
82.31
150.19
181.11
192.51

Alkem Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
725.84
471.13
266.04
779.65
585.08
1,264.9
1,111.02
1,682.5
1,948.07
1,912.84
Cash Flow from Investing Activities
204.74
-294.06
-350.52
-318.37
-737.34
-994.87
-1,432.63
119.94
-1,010.55
-1,288.25
Cash Flow from Financing Activities
-927.27
-137.88
84.56
-378.94
79.15
-271.75
379.57
-1,760.82
-1,145.01
-810.99
Net Cash Flow
3.31
39.58
0.08
82.34
-73.11
-1.72
57.96
41.62
-207.49
-186.4

Alkem Labs Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
57.16%
56.74%
56.74%
56.74%
56.38%
55.66%
55.66%
55.13%
53.04%
51.2%
51.2%
51.2%
DII
15.43%
17.64%
14.94%
15.63%
18.57%
19.21%
18.01%
19.42%
21.8%
21.93%
21.54%
21.4%
FII
0%
0%
0%
9.11%
8.69%
9.02%
10.15%
9.41%
9.11%
9.48%
9.97%
10.16%
Public
20.86%
19.59%
18.86%
18.52%
16.36%
16.1%
16.18%
16.05%
16.05%
17.4%
17.3%
17.25%
Total Outstanding Shares
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
Total Shareholders
66,790
69,442
65,184
65,830
69,627
74,744
84,038
84,326
79,740
67,196
64,536
62,835

Mutual Funds that own Alkem Labs Stock

Check out the Mutual Funds with significant holdings in Alkem Labs.

Alkem Labs Corporate Actions

View detailed summary of the earnings and dividend history of Alkem Labs.

  • Alkem Laboratories Ltd Earnings Results

    Alkem Laboratories Ltd’s net profit fell -22.69% since last year same period to ₹236.46Cr in the Q4 2025-2026. On a quarterly growth basis, Alkem Laboratories Ltd has generated -62.82% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Alkem Laboratories Ltd Dividends February,2026

    In the quarter ending December 2025, Alkem Laboratories Ltd has declared dividend of ₹43.00 per share on 13 Feb 2026 - translating a dividend yield of 0.94%.

    Read More about Dividends

Alkem Labs News & Key Events

  • img

    Today's Timeline - 29 May

    08:14 AM

    -

    Brokerages gave mixed ratings on Alkem's Q4 results, with Nomura maintaining a Buy rating and JPMorgan a Neutral rating.

    09:03 AM

    -

    Alkem aims for growth in FY27, focusing on execution and expanding its pipeline, despite potential short-term challenges.

    09:19 AM

    -

    Alkem's EBITDA rose 32% YoY; HDFC Securities raised the target price to ₹2,230, citing improving margins and growth visibility.

  • img

    Today's Timeline - 29 May

    10:24 AM

    -

    Alkem's stock surged over 6% after strong revenue growth and positive FY27 outlook, with a new generic launch expected.

    02:40 PM

    -

    Alkem reported a 22.7% decline in Q4 net profit but revenue rose 14.6%, with a final dividend of ₹10 per share.

Indices Featuring Alkem Labs Stock

Check stock indices that include Alkem Labs.

NIFTY PHARMA

₹24,345.80

-1.50 (▲370.20%)

Nifty LargeMidcap 250

₹16,304.65

-1.41 (▲233.05%)

Nifty Midcap 150

₹22,571.40

-1.37 (▲313.50%)

Nifty 500

₹22,657.00

-1.35 (▲310.40%)

BSE Healthcare

₹46,806.42

-1.41 (▲667.13%)

BSE 200

₹11,035.46

-1.39 (▲156.05%)

S&P BSE 150 MidCap

₹16,487.34

-1.25 (▲209.06%)

Nifty 200

₹13,663.70

-1.43 (▲197.90%)

BSE 500

₹35,417.64

-1.34 (▲481.52%)

Nifty Midcap 100

₹61,723.80

-1.33 (▲835.05%)

Nifty Midcap 50

₹17,490.55

-1.49 (▲264.40%)

S&P BSE 400 MidSmallCap

₹12,233.77

-1.04 (▲128.61%)

Nifty Healthcare

₹15,392.75

-1.86 (▲291.20%)

Nifty MidSmallcap 400

₹20,515.85

-1.13 (▲234.65%)

S&P BSE 250 LargeMidCap

₹10,502.67

-1.43 (▲152.09%)

Insights on Alkem Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 9.97% to 10.16% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ALKEM stock has moved up by 2.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 43.6% return, outperforming this stock by 40.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 51.20% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 166.0% return, outperforming this stock by 103.2%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 17.30% to 17.25% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 16.06% to 15.57% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 765.06 Cr → 236.46 Cr (in ₹), with an average decrease of 39.8% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 4.10K Cr → 3.80K Cr (in ₹), with an average decrease of 3.7% per quarter

Alkem Labs Stock Futures & Options Contracts

View the latest movement in Alkem Labs Futures & Options, including strike prices, expiry dates, and percentage changes.

Alkem Labs Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ALKEM 30 Jun ₹6000 Call
June 30, 2026
₹6000
₹37
5.15
16.17%
ALKEM 30 Jun ₹5800 Call
June 30, 2026
₹5800
₹75
12.05
19.14%
ALKEM 30 Jun ₹5700 Call
June 30, 2026
₹5700
₹102
23.2
29.44%
ALKEM 30 Jun ₹5600 Call
June 30, 2026
₹5600
₹140
30.45
27.8%

Alkem Labs Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ALKEM 30 Jun Fut
June 30, 2026
-
₹5563.5
162.04
3%
ALKEM 28 Jul Fut
July 28, 2026
-
₹5547
148.98
2.76%
ALKEM 25 Aug Fut
August 25, 2026
-
₹5530.5
132.78
2.46%

About Alkem Laboratories Ltd

Alkem Laboratories Ltd is a leading pharmaceutical company founded in 1973 by Mr. Samir C. Desai.

With its headquarters in Mumbai, India, Alkem Laboratories is engaged in the manufacture of a wide range of pharmaceutical products across multiple therapeutic categories, including cardiovascular, central nervous system, gastro-intestinal, anti-infective, diabetology, and nutrition. The company has a strong presence in the Indian market and exports its products to over 50 countries.

Revenue: ₹3,603.32Cr as on March 2026 (Q4 FY26)
Net Profit: ₹251.68Cr as on March 2026 (Q4 FY26)
Listing date: 23 Dec, 2015
Chairperson Name: Basudeo N Singh
OrganisationAlkem Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOBasudeo N Singh
E-voting on sharesClick here to vote

FAQs

What is Alkem Labs share price today?

Alkem Labs share price today stands at ₹5498 as on at the close of the market. Alkem Labs share today touched a day high of ₹5789 and a low of ₹5472.

What is the 52 week high and 52 week low range for Alkem Labs share?

Alkem Labs touched a 52 week high of ₹5933.5 and a 52 week low of ₹4716.2. Alkem Labs share price today i.e. is closed at ₹5498, which is -7.34% down from its 52 week high and 16.58% up from its 52 week low.

What is Alkem Labs's market capitalisation today?

Alkem Labs market capitalisation is ₹65,180.86 Cr as on .

How to buy Alkem Labs shares?

To buy Alkem Labs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ALKEM or Alkem Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Alkem Labs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Alkem Labs trading volume today?

Alkem Labs trading volume is 14.05L as on . This means that 14.05L shares of Alkem Labs were bought and sold on the stock market during today's trading session.